Purpose
|
Avasimibe inhibits ACAT with IC50 of 3.3 μM, also inhibits human P450 isoenzymes CYP2C9, CYP1A2 and CYP2C19 with IC50 of 2.9 μM, 13.9 μM and 26.5 μM, respectively.
|
Characteristics
|
Target: CYP inhibitor Receptor: CYP2C9,CYP1A2, CYP2C19 Status: INN
|
Purification
|
All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.
|
Purity
|
98.90?%
|
Formula
|
C29H43NO4S
|
Solubility
|
200 mM in DMSO
|